ResMed | RMD - Trade Debtors

Stock Price
215.87
Daily Change
-6.15 -2.77%
Monthly
-1.89%
Yearly
-9.20%
Q2 Forecast
215.15

ResMed reported $985.63M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Ansell USD 231.1M 15.4M Dec/2025
Artivion USD 103.68M 6.31M Dec/2025
AtriCure USD 66.65M 3.67M Dec/2025
Baxter International USD 2.01B 231M Dec/2025
Cochlear AUD 568.4M 17.5M Dec/2025
Cooper Companies USD 807.1M 21.9M Dec/2025
CSL USD 4.32B 1.35B Dec/2025
Dexcom USD 1.28B 167.3M Dec/2025
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Fisher Paykel Healthcare NZD 335.7M 16.5M Dec/2025
Globus Medical USD 743.66M 55.54M Dec/2025
Haemonetics USD 195.71M 11.36M Dec/2025
Idexx Laboratories USD 552.38M 14.5M Dec/2025
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 516.9M 54.7M Dec/2025
Integra LifeSciences USD 278.85M 16.69M Dec/2025
Intuitive Surgical USD 1.6B 68.3M Mar/2026
Masimo USD 391.9M 36M Dec/2025
Medtronic USD 6.36B 30M Dec/2025
Philips EUR 3.8B 266M Dec/2025
Ramsay Health Care AUD 2.48B 22.3M Dec/2025
ResMed USD 985.63M 78.36M Dec/2025
Sigma Healthcare AUD 2.56B 2.23B Dec/2025
Sonic Healthcare AUD 1.39B 23.76M Dec/2024
Steris USD 990.6M 43.3M Dec/2025
Teleflex USD 345.58M 247.07M Dec/2025
Thermo Fisher Scientific USD 9.2B 304M Mar/2026